Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012701 |
---|---|
Receipt number | R000014802 |
Scientific Title | A phase II study of nab-Paclitaxel therapy in reductive dose for patients with advanced/recurrent gastric cancer after prior treatments including fluoropyrimidine (OGSG 1302) |
Date of disclosure of the study information | 2013/12/28 |
Last modified on | 2022/09/25 20:44:51 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/25 22:46:39 | ||
2 | Update | 2014/12/25 23:53:09 | Institutions |
|
3 | Update | 2014/12/25 23:53:46 | Anticipated trial start date |
|
4 | Update | 2015/01/28 02:55:15 | Recruitment status |
|
5 | Update | 2015/01/28 02:57:55 | Institute Institute Institutions |
|
6 | Update | 2015/06/10 00:58:43 | Email Institutions |
|
7 | Update | 2015/07/13 19:35:59 | Organization Organization Category of Funding Organization |
|
8 | Update | 2015/07/13 19:51:04 | Key inclusion criteria Key inclusion criteria |
|
9 | Update | 2015/07/13 19:53:04 | Last follow-up date |
|
10 | Update | 2015/07/13 20:06:15 | Organization Organization Division name Address Address TEL |
|
11 | Update | 2015/07/15 23:03:43 | Email |
|
12 | Update | 2015/12/25 21:35:56 | Institutions |
|
13 | Update | 2016/04/10 19:15:30 | Name of primary person or sponsor Organization |
|
14 | Update | 2017/01/07 23:06:21 | Last follow-up date |
|
15 | Update | 2017/01/08 00:51:29 | Key inclusion criteria Key inclusion criteria |
|
16 | Update | 2018/01/20 20:58:25 | Recruitment status |
|
17 | Update | 2018/04/30 23:57:08 | Email |
|
18 | Update | 2018/05/10 20:35:22 | Email |
|
19 | Update | 2018/08/01 21:39:06 | UMIN ID1 |
|
20 | Update | 2018/08/01 21:43:48 | Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL Institutions |
|
21 | Update | 2018/08/08 19:51:09 | Organization Organization Division name Address Address TEL |
|
22 | Update | 2018/10/04 20:39:07 | Last follow-up date |
|
23 | Update | 2018/10/07 14:11:05 | Last follow-up date |
|
24 | Update | 2019/07/20 11:04:21 | Number of participants that the trial has enrolled |
|
25 | Update | 2020/01/05 20:47:23 | Date of IRB Date analysis concluded |
|
26 | Update | 2020/01/05 20:49:19 | Results Delayed Results Delay Reason Results Delay Reason |
|
27 | Update | 2020/01/22 22:24:50 | Recruitment status Date of IRB |
|
28 | Update | 2022/09/25 20:44:51 | URL releasing protocol Publication of results URL related to results and publications Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |